Trial
NCT03070132
802NP301 Efficacy and Safety Study of BIIB074 in Participants With Trigeminal Neuralgia
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Biogen
Collaborators
—
Condition
Trigeminal Neuralgia
Intervention
BIIB074
Why stopped
Sponsor Decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-05-06